BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27515515)

  • 1. The preventative role of exogenous melatonin administration to patients with advanced cancer who are at risk of delirium: study protocol for a randomized controlled trial.
    Bush SH; Lacaze-Masmonteil N; McNamara-Kilian MT; MacDonald AR; Tierney S; Momoli F; Agar M; Currow DC; Lawlor PG
    Trials; 2016 Aug; 17():399. PubMed ID: 27515515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin to prevent delirium in patients with advanced cancer: a double blind, parallel, randomized, controlled, feasibility trial.
    Lawlor PG; McNamara-Kilian MT; MacDonald AR; Momoli F; Tierney S; Lacaze-Masmonteil N; Dasgupta M; Agar M; Pereira JL; Currow DC; Bush SH
    BMC Palliat Care; 2020 Oct; 19(1):163. PubMed ID: 33087111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Melatonin for Delirium in Intensive Care (Pro-MEDIC): study protocol for a randomised controlled trial.
    Martinez FE; Anstey M; Ford A; Roberts B; Hardie M; Palmer R; Choo L; Hillman D; Hensley M; Kelty E; Murray K; Singh B; Wibrow B
    Trials; 2017 Jan; 18(1):4. PubMed ID: 28061873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study protocol for a prospective randomised double-blind placebo-controlled clinical trial investigating a Better Outcome with Melatonin compared to Placebo Administered to normalize sleep-wake cycle and treat hypoactive ICU Delirium: the Basel BOMP-AID study.
    Hollinger A; von Felten S; Sutter R; Huber J; Tran F; Reinhold S; Abdelhamid S; Todorov A; Gebhard CE; Cajochen C; Steiner LA; Siegemund M
    BMJ Open; 2020 Apr; 10(4):e034873. PubMed ID: 32354780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of oral melatonin on critically ill adult patients with ICU sleep deprivation: study protocol for a randomized controlled trial.
    Huang H; Jiang L; Shen L; Zhang G; Zhu B; Cheng J; Xi X
    Trials; 2014 Aug; 15():327. PubMed ID: 25135124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial.
    Al-Aama T; Brymer C; Gutmanis I; Woolmore-Goodwin SM; Esbaugh J; Dasgupta M
    Int J Geriatr Psychiatry; 2011 Jul; 26(7):687-94. PubMed ID: 20845391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderate dose melatonin for the abatement and treatment of delirium in elderly general medical inpatients: study protocol of a placebo controlled, randomised, double blind trial.
    Clayton-Chubb DI; Lange PW
    BMC Geriatr; 2016 Feb; 16():54. PubMed ID: 26928392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of melatonin versus placebo on delirium in hip fracture patients: study protocol of a randomised, placebo-controlled, double blind trial.
    de Jonghe A; van Munster BC; van Oosten HE; Goslings JC; Kloen P; van Rees C; Wolvius R; van Velde R; Levi MM; Korevaar JC; de Rooij SE;
    BMC Geriatr; 2011 Jul; 11():34. PubMed ID: 21729284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of melatonin on physical fatigue and other symptoms in patients with advanced cancer receiving palliative care: A double-blind placebo-controlled crossover trial.
    Lund Rasmussen C; Klee Olsen M; Thit Johnsen A; Petersen MA; Lindholm H; Andersen L; Villadsen B; Groenvold M; Pedersen L
    Cancer; 2015 Oct; 121(20):3727-36. PubMed ID: 26178160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreasing Delirium through Music (DDM) in critically ill, mechanically ventilated patients in the intensive care unit: study protocol for a pilot randomized controlled trial.
    Khan SH; Wang S; Harrawood A; Martinez S; Heiderscheit A; Chlan L; Perkins AJ; Tu W; Boustani M; Khan B
    Trials; 2017 Nov; 18(1):574. PubMed ID: 29187230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Healthy Heart-Mind trial: melatonin for prevention of delirium following cardiac surgery: study protocol for a randomized controlled trial.
    Ford AH; Flicker L; Passage J; Wibrow B; Anstey M; Edwards M; Almeida OP
    Trials; 2016 Jan; 17():55. PubMed ID: 26822209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of 3-month melatonin supplementation for brain oxidative stress and sleep in mild cognitive impairment: protocol for a randomised, placebo-controlled study.
    Menczel Schrire Z; Phillips CL; Duffy SL; Marshall NS; Mowszowski L; La Monica HM; Gordon CJ; Chapman JL; Saini B; Lewis SJG; Naismith SL; Grunstein RR; Hoyos CM
    BMJ Open; 2021 Feb; 11(2):e041500. PubMed ID: 33568368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of melatonin for prevention of delirium in critically ill patients: a protocol for a multicentre, randomised, placebo-controlled study.
    Burry L; Scales D; Williamson D; Foster J; Mehta S; Guenette M; Fan E; Detsky M; Azad A; Bernard F; Rose L
    BMJ Open; 2017 Mar; 7(3):e015420. PubMed ID: 28363933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic melatonin for delirium in intensive care (Pro-MEDIC): a randomized controlled trial.
    Wibrow B; Martinez FE; Myers E; Chapman A; Litton E; Ho KM; Regli A; Hawkins D; Ford A; van Haren FMP; Wyer S; McCaffrey J; Rashid A; Kelty E; Murray K; Anstey M
    Intensive Care Med; 2022 Apr; 48(4):414-425. PubMed ID: 35220473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for a randomized, double blind, placebo controlled, crossover trial of Melatonin for treatment of Nocturia in adults with Multiple Sclerosis (MeNiMS).
    Delgado D; Canham L; Cotterill N; Cottrell D; Drake MJ; Inglis K; Owen D; White P
    BMC Neurol; 2017 Mar; 17(1):63. PubMed ID: 28347292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study in advanced cancer patients to evaluate the early transition to palliative care (the PREPArE trial): protocol study for a randomized controlled trial.
    do Carmo TM; Paiva BS; de Siqueira MR; da Rosa Lde T; de Oliveira CZ; Nascimento MS; Paiva CE
    Trials; 2015 Apr; 16():160. PubMed ID: 25872950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicomponent non-pharmacological intervention to prevent delirium for hospitalised people with advanced cancer: study protocol for a phase II cluster randomised controlled trial.
    Hosie A; Phillips J; Lam L; Kochovska S; Noble B; Brassil M; Kurrle SE; Cumming A; Caplan GA; Chye R; Le B; Ely EW; Lawlor PG; Bush SH; Davis JM; Lovell M; Brown L; Fazekas B; Cheah SL; Edwards L; Agar M
    BMJ Open; 2019 Jan; 9(1):e026177. PubMed ID: 30696686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical analysis plan for the Prophylactic Melatonin for Delirium in Intensive Care (ProMEDIC): a randomised controlled trial.
    Wibrow B; Martinez FE; Ford A; Kelty E; Murray K; Ho KM; Litton E; Myers E; Anstey M
    Trials; 2021 Jan; 22(1):7. PubMed ID: 33402209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Role of Exogenous Melatonin Supplement in Delirium Prevention in Critically Ill Patients: A Double-Blind Randomized Pilot Study.
    Abbasi S; Farsaei S; Ghasemi D; Mansourian M
    Iran J Pharm Res; 2018; 17(4):1571-1580. PubMed ID: 30568713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of volatile anesthetic agents for long-term critical care sedation (VALTS): study protocol for a pilot randomized controlled trial.
    Jerath A; Ferguson ND; Steel A; Wijeysundera D; Macdonald J; Wasowicz M
    Trials; 2015 Dec; 16():560. PubMed ID: 26646404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.